BRAMBILLA, GIANMARIA
 Distribuzione geografica
Continente #
NA - Nord America 4.723
AS - Asia 2.158
EU - Europa 1.910
SA - Sud America 333
Continente sconosciuto - Info sul continente non disponibili 119
AF - Africa 58
OC - Oceania 5
Totale 9.306
Nazione #
US - Stati Uniti d'America 4.410
SG - Singapore 830
CN - Cina 444
DE - Germania 341
IT - Italia 313
VN - Vietnam 284
CA - Canada 275
RU - Federazione Russa 271
HK - Hong Kong 264
SE - Svezia 260
BR - Brasile 238
IE - Irlanda 205
UA - Ucraina 164
FR - Francia 108
GB - Regno Unito 101
IN - India 78
BD - Bangladesh 57
FI - Finlandia 53
AR - Argentina 33
KR - Corea 26
TR - Turchia 26
IQ - Iraq 24
BE - Belgio 19
MX - Messico 18
JP - Giappone 17
PL - Polonia 16
NL - Olanda 15
ZA - Sudafrica 15
CO - Colombia 13
ES - Italia 13
PK - Pakistan 13
EC - Ecuador 12
CL - Cile 11
ID - Indonesia 11
PH - Filippine 11
VE - Venezuela 11
SA - Arabia Saudita 9
EG - Egitto 8
PY - Paraguay 8
AE - Emirati Arabi Uniti 7
CZ - Repubblica Ceca 7
MA - Marocco 7
UZ - Uzbekistan 7
ET - Etiopia 6
EU - Europa 6
LB - Libano 6
JM - Giamaica 5
KE - Kenya 5
KZ - Kazakistan 5
NP - Nepal 5
TH - Thailandia 5
AT - Austria 4
AZ - Azerbaigian 4
IR - Iran 4
JO - Giordania 4
MY - Malesia 4
PE - Perù 4
RO - Romania 4
AU - Australia 3
BG - Bulgaria 3
BJ - Benin 3
CH - Svizzera 3
DZ - Algeria 3
GR - Grecia 3
HN - Honduras 3
NI - Nicaragua 3
OM - Oman 3
TN - Tunisia 3
BA - Bosnia-Erzegovina 2
KH - Cambogia 2
LT - Lituania 2
NZ - Nuova Zelanda 2
PA - Panama 2
PS - Palestinian Territory 2
SN - Senegal 2
TT - Trinidad e Tobago 2
UY - Uruguay 2
AL - Albania 1
AM - Armenia 1
AO - Angola 1
BB - Barbados 1
BO - Bolivia 1
BZ - Belize 1
CG - Congo 1
CI - Costa d'Avorio 1
CR - Costa Rica 1
DO - Repubblica Dominicana 1
GE - Georgia 1
KG - Kirghizistan 1
KW - Kuwait 1
LU - Lussemburgo 1
LY - Libia 1
MN - Mongolia 1
MU - Mauritius 1
SC - Seychelles 1
SK - Slovacchia (Repubblica Slovacca) 1
SV - El Salvador 1
SY - Repubblica araba siriana 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 9.194
Città #
Singapore 469
Ashburn 437
Woodbridge 365
Ann Arbor 351
San Jose 281
Fairfield 273
Hong Kong 257
Chandler 256
Houston 254
Frankfurt am Main 217
Toronto 206
Dublin 196
Jacksonville 175
Seattle 129
New York 119
Dearborn 117
Cambridge 112
Wilmington 108
Milan 106
Council Bluffs 84
Hanoi 80
Ho Chi Minh City 78
Los Angeles 75
Santa Clara 75
Princeton 74
Beijing 72
Chicago 64
Nanjing 50
The Dalles 42
Dallas 40
Lauterbourg 37
Lachine 33
Lawrence 32
Altamura 30
Rome 30
Boardman 29
Buffalo 26
Shanghai 26
Seoul 25
Moscow 24
São Paulo 24
Hefei 22
Munich 20
Brussels 17
Nanchang 17
Orem 17
Phoenix 17
Shenyang 16
Tianjin 16
Hebei 15
Ottawa 14
San Diego 14
Belo Horizonte 13
Helsinki 13
Tokyo 12
Baghdad 11
Chennai 11
Warsaw 11
Andover 10
Changsha 10
Düsseldorf 10
Figino 10
Fremont 10
Guangzhou 10
Haiphong 10
Da Nang 9
Hangzhou 9
London 9
Lissone 8
Miami 8
Montreal 8
Turin 8
Zhengzhou 8
Boston 7
Columbus 7
Ningbo 7
Rio de Janeiro 7
Turku 7
Addis Ababa 6
Atlanta 6
Caracas 6
Denver 6
Dhaka 6
Guayaquil 6
Jinan 6
Medellín 6
Mexico City 6
Newark 6
Norwalk 6
Porto Alegre 6
Salt Lake City 6
Santiago 6
Stockholm 6
Tampa 6
Cairo 5
Jiaxing 5
Johannesburg 5
Las Vegas 5
Pune 5
Washington 5
Totale 6.032
Nome #
The Pamela study: main findings and perspectives 327
Regional differences in sympathetic activation in lean and obese normotensive individuals with obstructive sleep apnoea 316
It is never too late for a genetic disease: a case of a 79-year-old man with persistent hypokalemia 311
Prevalence of cardiovascular risk factors in an unselected Italian population. Results of the CardioLab Project 2004-2008 309
Similarities and differences between renal sympathetic denervation and carotid baroreceptor stimulation 308
Comparative effects of nebivolol and metoprolol on red cell distribution width and neutrophil/lymphocyte ratio in patients with newly diagnosed essential hypertension 307
Prognostic Significance of Left Atrial Enlargement in a General Population: Results of the PAMELA Study 300
Differential effects of enalapril-felodipine versus enalapril-lercanidipine combination drug treatment on sympathetic nerve traffic and metabolic profile in obesity-related hypertension 295
Role of ambulatory blood pressure monitoring in resistant hypertension 288
Structural and functional alterations of subcutaneous small resistance arteries in severe human obesity 280
Chronic baroreflex activation effects on sympathetic nerve traffic, baroreflex function, and cardiac haemodynamics in heart failure: a proof-of-concept study 278
New-onset left atrial enlargement in a general population 278
Neuroadrenergic disarray in pseudo-resistant and resistant hypertension 278
Blood pressure (clinic, home, 24-h) profiles and clinical correlates in 264
Clinic, home, 24-hour blood pressure profiles and clinical correlates in resistant hypertension: data from the PAMELA Study 263
Different neuroadrenergic activation and baroreflex function in resistant and pseudoresistant hypertension: a microneurographic study 260
Total cardiovascular risk, blood pressure variability and adrenergic overdrive in hypertension: evidence, mechanisms and clinical implications 251
Differential patterns of regional neuroadrenergic cardiovascular drive in acromegalic disease 251
Blood Pressure Responses to Renal Denervation Precede and Are Independent of the Sympathetic and Baroreflex Effects 246
Sympathetic nerve traffic, insulin resistance and baroreflex control of circulation in patients with resistant hypertension 246
Failure of monolateral renal nerve ablation to exert sympathoinhibitory and blood pressure lowering effects in a patient with resistant hypertension: a case report 243
Prognostic value of "partial" and "true" white coat hypertension: data from 16 year follow-up in the PAMELA population 242
Targets for body fat, blood pressure, lipids, and glucose-lowering interventions in healthy older people 237
Long-term prognistic value of white-coat hypertension: an insight from diagnostic use of both ambulatory and home blood pressure measurements 232
Reduced Insulin Sensitivity is Associated with Adrenergic Overdrive Independently on Obesity and Hypertension 228
Novel Antihypertensive Therapies: Renal Sympathetic Nerve Ablation and Carotid Baroreceptor Stimulation 222
Marked sympathetic activation and baroreflex dysfunction in true resistant hypertension 214
Prevalence and clinical characteristics of patients with true resistant hypertension in central and Eastern Europe: data from the BP-CARE study 211
The sympathetic nervous system and new nonpharmacologic approaches to treating hypertension: a focus on renal denervation 207
The role of carotid baroreceptor stimulation 206
Sympathetic nerve traffic and blood pressure changes after bilateral renal denervation in resistant hypertension: A time-integrated analysis 205
Effects of Renal Denervation on Sympathetic Nervous System Activity 205
Reduced insulin sensitivity is associated with adrenergic overdrive in hemochromatosis independently on obesity and hypertension 203
Dissociation between the behaviour of arterial stiffness and muscel sympathetic nerve traffic in patients with htart failure treated with chronic baroreflex activation 174
Prevalence and main features of resistant hypertension in central and eastern Europe: the BP-CARE Study 163
Metabolic profile and control by treatment and relationships with blood pressure values in patients from central and easter European countries: the BP-CARE metaboli study 155
Prevalence and correlates of new-onset left ventricular geometric abnormalities in a general population 153
CPAP in acute pulmonary edema. Our experience of the nurse role in the out of hospital life support 150
Totale 9.306
Categoria #
all - tutte 31.298
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 31.298


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022351 0 0 39 39 35 27 12 25 20 39 38 77
2022/2023882 92 327 70 82 33 144 3 62 54 3 9 3
2023/2024576 12 20 25 46 73 149 130 24 37 4 3 53
2024/20251.235 66 165 59 50 117 18 40 64 171 190 108 187
2025/20263.151 330 126 223 293 403 140 415 124 265 336 275 221
2026/2027339 57 126 156 0 0 0 0 0 0 0 0 0
Totale 9.306